#biosimilars : grosses discussions prévues en COMEDIMS 😅 @SFPOofficiel CT-P6 compared with reference trastuzumab https://t.co/r81kF55pA7
#biosimilars : grosses discussions prévues en COMEDIMS 😅 @SFPOofficiel CT-P6 compared with reference trastuzumab https://t.co/r81kF55pA7